Table 1 Pretreatment characteristics of 184 patients with mid/low rectal cancer
Variable | TME group (cases [%]) | CCRT + TME group (cases [%]) | χ 2 | P |
|---|---|---|---|---|
Total | 94 | 90 | Â | Â |
Sex | Â | Â | 1.199 | 0.273 |
 Male | 51 (54.3) | 56 (62.2) |  |  |
 Female | 43 (45.7) | 34 (37.8) |  |  |
Distance from the lower tumor margin to the anal verge | 1.119 | 0.290 | ||
 ≤5 cm | 47 (50.0) | 52 (57.8) |  |  |
>5-10Â cm | 47 (50.0) | 38 (42.2) | Â | Â |
T stage | Â | Â | 6.833 | 0.033 |
 cT2 | 8 (8.5) | 2 (2.2) |  |  |
 cT3 | 69 (73.4) | 60 (66.7) |  |  |
 cT4 | 17 (18.1) | 28 (31.1) |  |  |
N stage | Â | Â | 3.305 | 0.069 |
 cN0 | 48 (51.1) | 33 (36.7) |  |  |
 cN+ | 46 (48.9) | 57 (63.3) |  |  |
Clinical stage | Â | Â | 2.752 | 0.097 |
 II | 48 (51.1) | 33 (36.7) |  |  |
 III | 46 (48.9) | 57 (63.3) |  |  |